-

Eurofins Technologies Announces AOAC Performance Tested MethodsSM Status for SENSISpec Ingezim Gluten R5 Kit

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of gluten, SENSISpec Ingezim Gluten R5, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 052005) for use with gluten free bread, oat flour and stainless steel surfaces.

The assay was developed by Eurofins Ingenasa, a biotechnology company with more than 20 years of experience in food allergen analysis and a member of Eurofins Technologies’ group of companies.

The presence of gluten in foods has health implications for individuals with celiac disease – a genetic, immune system disease affecting roughly 1% of people in North America and Europe that damages the lining of the small intestine and interferes with absorption of nutrients. Since there is currently no cure for it, management of celiac disease is through the elimination of gluten from diet, requiring labeling and traceability within the food production process, from raw material to final product.

The SENSISpec Ingezim Gluten R5 uses the R5 monoclonal antibody for specific detection of prolamin sequences from wheat, rye and barley. Research studies have shown that the R5 antibody specifically targets the component of the gluten fraction that is believed to be directly responsible for celiac disease.

The kit is provided in a 96 well format and includes all necessary reagents including extraction solution. With its limit of quantification of 3,4 ppm gluten (1.7 ppm gliadin) it is also one of the most sensitive test kits in the market, creating additional safety for consumers with celiac disease. It can be deployed in allergen risk management programs of food manufacturers as well as a validated assay in ISO17025 accredited laboratories.

Receiving the AOAC Performance Tested MethodsSM status demonstrates Eurofins Technologies’ commitment to providing high quality test methods for our food safety customers. The SENSISpec Ingezim Gluten R5 is a key component of Eurofins Technologies allergen management product line which covers a very comprehensive range of parameters.

About Eurofins Technologies

Building on the experience and scientific excellence of the Eurofins Group, Eurofins Technologies is a global provider of diagnostic technologies in the field of bioanalytical testing for the food, feed, environmental, animal health, and clinical diagnostics industries.

More information: Eurofins Technologies.

Contacts

For more information, visit www.eurofins-technologies.com or contact:

Belen Berreiro
E-mail: ir@eurofins.com

Eurofins Technologies

BOURSE:ERF

Release Versions

Contacts

For more information, visit www.eurofins-technologies.com or contact:

Belen Berreiro
E-mail: ir@eurofins.com

More News From Eurofins Technologies

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd February to 06th February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/02/2026 FR0014000MR3 10 000 68.3375 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 03/02/2026 FR0014000MR3 10 000 67.9091 XPAR EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Viracor BioPharma Expands Bioanalytical Capabilities

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical...
Back to Newsroom